In addition to the spin-off companies in this field, the University has also encouraged its departments to collaborate with some of the giants of the medical and pharmaceutical worlds, such as Glaxo Wellcome, SmithKline Beecham and Zeneca. Funding for new developments also comes from charities. The technology is being developed with a US-based company and the Cancer Research Campaign's technology transfer subsidiary. At the University's Clinical School, international collaborations and support are part of everyday life. Among them is Professor John Todd, whose work on genetic screening for diabetes has a high international profile.
Companies also recognise the value of collaborating to help tomorrow's top researchers.